2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1215904354 MD
Verify on CMS →

GULNAZ MIRZA, MD

Endocrinology, Diabetes & Metabolism Physician in BOYNTON BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 540 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
50%
generic claims · 50% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$490.73
12 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GULNAZ MIRZA, MD reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 4,514 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
5K
Part D claims, 2023
50%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GULNAZ MIRZA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GULNAZ MIRZA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GULNAZ MIRZA, MD?

High performer (top quartile)

NPI registry status

Active

Issued 03/08/2006

NPI 1215904354

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

4,514 71% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Medicare quality performance — MIPS

GULNAZ MIRZA, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GULNAZ MIRZA, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 8190 S JOG RD, BOYNTON BEACH, FL, 33472, with a listed phone of (561) 964-1411. NPI 1215904354 was issued on 03/08/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MIRZA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,514 prescription claims written by this provider, covering 540 Medicare beneficiaries and totaling roughly $2.6 million in drug spend, split 50% brand-name and 50% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 94.8767), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8190 S JOG RD
BOYNTON BEACH, FL 33472

Provider Details

NPI 1215904354
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 03/08/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
94.8767
Quality
100
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GULNAZ MIRZA, MD. Source: openpaymentsdata.cms.gov.

Total received

$491

Largest payer

SANOFI-AVENTIS U.S. LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to GULNAZ MIRZA, MD. To verify GULNAZ MIRZA, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

GULNAZ MIRZA, MD — brand share 50.0%
Specialty average (est.)

50% brand-name claims vs 50% generic, on 4,514 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,514
Total Claims
$2.6M
Total Drug Cost
540
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
11,002
Total Day Supply
327,687
Brand vs Generic
50% brand / 50% generic
Brand Drug Cost
$2.4M
Generic Drug Cost
$50K

Patient Demographics

Average Patient Age
72.4 years
Avg HCC Risk Score
2.16
Gender Split
60% female / 40% male
Age Distribution
<65: 80, 65-74: 216, 75-84: 192, 85+: 52

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GULNAZ MIRZA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
398
Metformin Hcl
254
Ozempic
Semaglutide
230
Jardiance
Empagliflozin
211
Novolog Flexpen
Insulin Aspart
210
Glimepiride
191
Mounjaro
Tirzepatide
167
Atorvastatin Calcium
133
Nateglinide
118
Trulicity
Dulaglutide
116

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How GULNAZ MIRZA, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

GULNAZ MIRZA, MD's 4,514 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as MIRZA.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GULNAZ MIRZA, MD's specialty?
GULNAZ MIRZA, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in BOYNTON BEACH, Florida. Credentials: MD.
How much does GULNAZ MIRZA, MD prescribe under Medicare Part D?
In 2023, GULNAZ MIRZA, MD wrote 4,514 Medicare Part D claims totaling $2.6M in drug costs for 540 beneficiaries.
What is GULNAZ MIRZA, MD's Medicare quality score?
GULNAZ MIRZA, MD has a CMS MIPS Final Score of 100/100 (Quality: 94.8767). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GULNAZ MIRZA, MD located?
GULNAZ MIRZA, MD is located at 8190 S JOG RD, BOYNTON BEACH, FL, 33472. Phone: (561) 964-1411.
What is GULNAZ MIRZA, MD's NPI number?
GULNAZ MIRZA, MD's National Provider Identifier (NPI) is 1215904354, issued on 03/08/2006.
Does GULNAZ MIRZA, MD prescribe more brand-name or generic drugs?
GULNAZ MIRZA, MD's prescribing is 50% brand-name and 50% generic drugs by claim count, with $2.4M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does GULNAZ MIRZA, MD prescribe most often?
Based on 2023 Medicare Part D data, GULNAZ MIRZA, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GULNAZ MIRZA, MD accept Medicare?
GULNAZ MIRZA, MD appears in CMS Medicare data with 4,514 Part D claims and 540 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GULNAZ MIRZA, MD's credentials?
GULNAZ MIRZA, MD's NPI is 1215904354 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology